Skip to main content
Premium Trial:

Request an Annual Quote

Roche Gets FDA OK for MDx MRSA Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche said after the close of the market Thursday that the US Food and Drug Administration has cleared its LightCycler MRSA Advanced Test for detection of methicillin-resistant Staphylococcus aureus.

The PCR-based test is a qualitative in vitro diagnostic test for direct detection of nasal colonization with bacterial MRSA. It is designed to aid in preventing and controlling MRSA infections in healthcare settings and can provide results within two hours, said Roche.

The test is run on Roche's LightCycler real-time PCR instrument.

Last month, the FDA cleared for marketing Cepheid's latest test for MRSA, the Xpert SA Nasal Complete. That test is designed for the detection and differentiation of Staphylococcus aureas and methicillin-resistant Staphylococccus aureus colonization in under one hour, according to Cepheid.

Becton Dickinson also makes a molecular MRSA test that identifies and differentiates Staphylococcus aureas and methicillin-resistant Staphylococccus aureus.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.